INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
RE
Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc
ACIAlbertsons Companies, Inc.
Tax withholding
F—
6,077 sh
Apr 21, 2026Apr 23, 2026
Page 912 of 1737
← PrevNext →
traded Apr 21, 2026
+2d
SEC Form 4

Evidence

13
MA
Mills Joshua A.Director
NONENONEKKR Infrastructure Conglomerate LLC
Grant or award
A—
395 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
KS
Klevorn Marcy SDirector
NTRSNORTHERN TRUST CORP
Grant or award
A—
989 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
MM
Moriarty Thomas MEVP, M&A and Corporate Affairs
ACIAlbertsons Companies, Inc.
Tax withholding
F—
13.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
BR
Backus RobertEVP Retail Operations East
ACIAlbertsons Companies, Inc.
Tax withholding
F—
7,145 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
JL
Jackson Sharon L.EVP, Chief Banking Officer
FVCBFVCBankcorp, Inc.
Grant or award
A—
3,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
NG
Nassy Michael G.Sr EVP, Chief Credit Officer
FVCBFVCBankcorp, Inc.
Grant or award
A—
9,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
LE
Lopez Patricia EDirector
DPZDOMINOS PIZZA INC
Grant or award
A—
515 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
85 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
MM
Moriarty Thomas MEVP, M&A and Corporate Affairs
ACIAlbertsons Companies, Inc.
Tax withholding
F—
9,355 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
92 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Option exercise
M—
9,322 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

13
MJ
Morales Vincent JDirector
TDYTELEDYNE TECHNOLOGIES INC
Grant or award
A—
319 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
WE
Wolf Dana ElizabethDirector
ATENA10 Networks, Inc.
Grant or award
A—
7,233 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
DF
Dicken Scott FraserChief Commercial Officer
PSNYPolestar Automotive Holding UK PLC
Grant or award
A—
92 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
SD
Schmitz Ronald D.Director
NONENONEKKR Private Equity Conglomerate LLC
Grant or award
A—
338 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
SW
Somerhalder John W IiDirector
NONENONEKKR Infrastructure Conglomerate LLC
Grant or award
A—
1,186 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
63.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
LM
Larson MichelleChief Merchandising Officer
ACIAlbertsons Companies, Inc.
Option exercise
M—
40.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
300.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
HJ
Henricsson Nina JosefinChief Human Resources Officer
PSNYPolestar Automotive Holding UK PLC
Option exercise
M—
176 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
128.6K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
110.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
SG
Simmonds Sidney GDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Option exercise
M—
24.5K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
MS
Mccollam SharonPresident & CFO
ACIAlbertsons Companies, Inc.
Tax withholding
F—
15.4K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
33.9K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
81.8K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
309.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
RE
Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc
ACIAlbertsons Companies, Inc.
Option exercise
M—
13.6K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
PL
Pei Melinda LitherlandDirector
BIOBIO.BBIO-RAD LABORATORIES, INC.
Grant or award
A—
369 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
151.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DF
Dicken Scott FraserChief Commercial Officer
PSNYPolestar Automotive Holding UK PLC
Option exercise
M—
176 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
6,750 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GJ
Geraghty JoannaDirector, CEO
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
446.4K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Option exercise
M—
12.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
TB
Thompson Teresa BrigidDirector
SNYRSynergy CHC Corp.
Grant or award
A—
25.8K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
1,181 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
60.2K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence